VGXI Supports Local Girl Scouts in the 2010 Body Forward Challenge
The Woodlands, Texas – September 28, 2010
VGXI, a world leader in DNA vaccine contract manufacturing, announced today that it is sponsoring a local Girl Scout chapter in its effort to compete in the First® LEGO® League, an international robotics competition for elementary and middle school students that focuses on real-world scientific related topics.
This year’s competition, the 2010 Body Forward Challenge, will explore the cutting-edge world of Biomedical Engineering to discover innovative ways to repair injuries, overcome genetic predispositions, and maximize the body’s potential, with the intended purpose of leading happier and healthier lives. The robotics component of the competition revolves around designing and programming LEGO Robots to complete challenging tasks. Additionally, the teams are required to research a related topic, develop their own creative solution, and prepare a multimedia presentation. The competitors work out solutions to the various problems they are given and then meet for regional tournaments to share their knowledge, compare ideas, and display their robots.
VGXI will provide coaching and host a team as they meet and practice for upcoming tournaments. Several women scientists at VGXI will also speak with the girls about possible educational and career paths in science and engineering.
“VGXI is excited to support our local Girl Scout Troop in the 2010 Body Forward Challenge. I hope through our involvement we can encourage these young girls to explore the opportunities a career in science can offer them,” said Brenda Reichert, VGXI’s Human Resources Manager.
About VGXI Inc.
VGXI Inc. is a leading provider of DNA plasmid manufacturing and development services for DNA vaccine and gene therapy research. The Company has an outstanding track record of success in manufacturing plasmid products under cGMP conditions for client companies’ clinical studies in the US and Europe, and its cGMP and non-cGMP products have passed rigorous reviews by several international regulatory agencies. VGXI’s ability to work with unique requirements and create custom manufacturing solutions is based on its patented manufacturing process, flexible cGMP production facility, and experienced development team. The recently announced research and pre-clinical production services extend the range of high-quality, research grade materials utilizing the same efficient service. This rapid turnaround program provides consistent materials to build a reliable pre-clinical dataset. For information, visit https://vgxii.com
Factors That May Affect Future Results
Materials in this Web site contain information that includes or is based upon forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. They use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with a discussion of potential future events, circumstances or future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. Any or all of our forward-looking statements here or in other publications may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed, and forward-looking statements may be adversely affected by factors, including general market conditions, competitive product development, product availability, current and future branded and generic competition, federal and state regulations and legislation, manufacturing issues, timing of the elimination of trade buying, patent positions, litigations and investigations.Our actual results may vary materially, and there are no guarantees about the performance or valuation of VGX stock. It is also important to read the disclosure notice contained in many of the individual VGX documents available on this Web site as many contain important information on such cautionary factors as of the date of the individual document. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports.